Latest filing published 08 Jul 2026 for IRLAB Therapeutics AB, €1,289.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Gamgort: trading record in brief
This profile gathers the share dealings of James Gamgort in IRLAB Therapeutics AB. The record holds 4 filings, for trades running from 7 July 2026 to 8 July 2026.
Every open-market trade on record is a purchase: 4 purchases worth €55k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €14k.
Most recently, on 9 July 2026, the filings show an open-market purchase worth €1,289 in IRLAB Therapeutics AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to James Gamgort
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,500 shares@ US$0.144.7% of flowAktieISIN SE0012675361FI:csv-35717e7a0931ae76cb93Canonical exit: 6 Oct 2026 (T+90)
- 200,000 shares@ US$0.1595.3% of flowAktieISIN SE0012675361FI:csv-844ff39e4cac1d0d42e2Canonical exit: 5 Oct 2026 (T+90)
2 of 2 declarations